ERBB2 and breast cancer: Based on the molecular expression of cell membrane receptors, the onset of breast cancer can be classified into four subtypes such as normal-like expression of receptors, molecular expression of cell surface estrogen receptor-positive (luminal), human epidermal growth factor receptor 2 (HER2) enriched, and basal-like cell surface receptors (3).